🔖
Cite This Article
KOÇAK, Z., HATİPOĞLU, O., ALTIAY, G., OKUMUŞ, D. (2022). Metachronous primary lung cancers: The importance of a lifelong follow up. Tüberküloz ve Toraks, Cilt: 64 - Sayı: 4, 315–316. https://ajindex.com/articles/618532
Journals / Tüberküloz ve Toraks / 2016 / Cilt: 64 - Sayı: 4
Metachronous primary lung cancers: The importance of a lifelong follow up
- Journal
- Tüberküloz ve Toraks
- Pages
- 315–316
- Publication Date
- 2022-11-05
- DOI
- —
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗References (2)
- Kim Y, Ko J, Cui Z, Abolhoda A, Ahn JS, Ou SH, et al. The EGFR T790M mutation in acquired resistance to an irreversible second-generation EGFR inhibitor. Mol Cancer Ther 2012;11:784-91
- Katakami N, Atagi S, Goto K, Hida T, Horai T, Inove A, et al. LUX-Lung 4: a phase II trial of afatinib in patients with advanced non-small-cell lung cancer who progressed during prior treatment with erlotinib, gefitinib, or both. J Clin Oncol 2013;31:3335-41.